Aberrant methylation of p16(INK4a) is an early event in lung cancer and a potential biomarker for early diagnosis - Wikidata - awgldk - TriplyDB

Aberrant methylation of p16(INK4a) is an early event in lung cancer and a potential biomarker for early diagnosis

Aberrant methylation of p16(INK4a) is an early event in lung cancer and a potential biomarker for early diagnosis

http://www.wikidata.org/entity/Q36324689

about

Epigenetic inactivation of RASSF1A in lung and breast cancers and malignant phenotype suppression Targeting the epigenome in lung cancer: expanding approaches to epigenetic therapy Surfactant protein DNA methylation: a new entrant in the field of lung cancer diagnostics? (Review)An overview of epigenetics and chemoprevention hMLH1 promoter hypermethylation is an early event in human endometrial tumorigenesis Lung cancer. 1: prevention of lung cancer Genetic alteration and gene expression modulation during cancer progression The molecular basis of lung cancer: molecular abnormalities and therapeutic implications Preneoplastic lesions of the lung Epigenetics and airways disease Epigenetics in non-small cell lung cancer: from basics to therapeutics Induced pluripotent stem cell technology for dissecting the cancer epigenome Cancer heterogeneity--a multifaceted view Epigenetics of lung cancer Genomic impact of cigarette smoke, with application to three smoking-related diseases Emerging technologies for studying DNA methylation for the molecular diagnosis of cancer Inactivation of hMLH1 and hMSH2 by promoter methylation in primary non-small cell lung tumors and matched sputum samples High risk of tobacco-related cancers in CDKN2A mutation-positive melanoma families Biomarkers in cancer staging, prognosis and treatment selection Lung cancer epigenetics: emerging biomarkers The epigenomics of cancer Global methylation profiling of lung cancer identifies novel methylated genes Methylation matters Strain-dependent lung tumor formation in mice transplacentally exposed to 3-methylcholanthrene and post-natally exposed to butylated hydroxytoluene DNA methylation-based biomarkers for early detection of non-small cell lung cancer: an update Some molecular and clinical aspects of genetic predisposition to malignant melanoma and tumours of various site of origin Silencing of Hint1, a novel tumor suppressor gene, by promoter hypermethylation in hepatocellular carcinoma Role of cell cycle regulators in lung carcinogenesis Pulmonary adenocarcinoma: a renewed entity in 2011 Long term transcriptional reactivation of epigenetically silenced genes in colorectal cancer cells requires DNA hypomethylation and histone acetylation Dose- and time- effect responses of DNA methylation and histone H3K9 acetylation changes induced by traffic-related air pollution Biomarkers of genome instability and cancer epigenetics.The role of DNA methylation as biomarkers in the clinical management of lung cancer.Emerging molecular markers of cancer.PPAR alpha inhibits vascular smooth muscle cell proliferation underlying intimal hyperplasia by inducing the tumor suppressor p16INK4a.Hypermethylation of the p16 (Ink4a) promoter in B6C3F1 mouse primary lung adenocarcinomas and mouse lung cell lines.Sequence-specific DNA binding activity of RNA helicase A to the p16INK4a promoter.DNA methylation, methyltransferases, and cancer.Cancer genomics identifies regulatory gene networks associated with the transition from dysplasia to advanced lung adenocarcinomas induced by c-Raf-1.Sex determining region Y-Box 2 (SOX2) is a potential cell-lineage gene highly expressed in the pathogenesis of squamous cell carcinomas of the lung.

P2860

Q24291194-1B694927-808F-41D1-8B02-BF1E17F169CA Q24609974-0B8406A7-F145-488E-8CDE-E625AEC2E47F Q24617128-851E7757-3AF9-4BE2-BA25-1ED91A211D15 Q24623823-399D27DF-40C0-4FEF-B05D-87F93F0F06F8 Q24670424-FDCDEDF7-D3E1-4706-B286-9100FDE46840 Q24678926-B82136B4-23C8-4801-BCBA-98CB60BA7B58 Q24798750-F52B043A-A56D-4D03-BF19-DBD8619C6FBA Q24802445-DAAE1DA9-7DEA-492C-BF5C-8D9A3168C030 Q24807204-807BC832-8C12-4D54-955A-C1C70280A894 Q25256981-A4B2E198-D68E-404B-B371-D5FECC799EE3 Q26749113-A334A8F9-29A6-4531-B184-6115665AF64F Q26801711-E369E913-DAD0-4695-835E-6F7F90FCC79F Q26829228-A8962C0C-881B-4519-96C9-E5EAE4A8286F Q26996766-E17AD8CA-1AA5-4FAA-B215-5CEF9D5E5521 Q27027763-4E955D41-6E8F-4088-9F74-5A4CDD71C30F Q28087759-8248B1F7-2EB3-4A31-B9C5-CD50059396C5 Q28183803-6E23350D-5E7B-4F26-927A-5E124D72A70D Q28242124-B72D8D7E-F9F2-4E6D-B82B-DADED83E41C4 Q28278305-93A8E772-2EF0-455A-B56B-A0494D337916 Q28285049-7F2557BF-B367-4F55-B340-21BE7C8F817E Q28289975-49C5147D-029E-4329-A087-3BD5D3E5F3B9 Q28360366-0165787C-4C34-48EE-A743-946E089BB2D5 Q28364163-585F0AF2-C387-4D40-B541-429C5CF855B2 Q28375629-C5287500-7B05-40AC-873B-259847F84D3D Q28386334-1D6CFB08-D9FB-4C31-85D2-1371EE137B84 Q28390768-BFF65946-D0D3-4F3B-B7FC-DAFD7699B366 Q28392002-1847A746-CDAC-416A-AF3B-7B1E0641EC07 Q28394676-BCC7C019-BF81-4FA4-803C-B646EAA885A2 Q28395348-DFDAE9DF-E940-4EDF-A6B0-C149C44CE4C5 Q28476454-0FA0CB18-C1A8-47EE-B113-4D6F17C2F338 Q29248414-E0E8E404-FF96-426E-8565-A646E2408603 Q30248745-1E14AE3F-B14E-4F99-8021-1407473B6396 Q30317739-FCE812EB-6C1A-43FF-9C38-1C29C3EA7A79 Q30330271-655D91CB-8DC4-45F4-8573-E8BC71391902 Q30476274-7CC3B168-BE67-4811-8599-E336D6BDF62C Q30912629-3ED8E357-9301-4228-A712-34FE6C43F0D2 Q30945379-3FE252D1-EDC9-46AE-B845-54D548F879E8 Q30993657-7A209079-FA61-47B0-9688-13C0659D42B1 Q33509293-16B462D8-155C-4FC7-9AD2-9CFD455A4607 Q33531781-95966669-4946-4288-9ED5-0B3744A2DA69

P2860

Aberrant methylation of p16(INK4a) is an early event in lung cancer and a potential biomarker for early diagnosis

http://www.wikidata.org/entity/Q36324689

description

1998 nî lūn-bûn

@nan

1998年の論文

@ja

1998年学术文章

@wuu

1998年学术文章

@zh-cn

1998年学术文章

@zh-hans

1998年学术文章

@zh-my

1998年学术文章

@zh-sg

1998年學術文章

@yue

1998年學術文章

@zh

1998年學術文章

@zh-hant

name

Aberrant methylation of p16(IN ...... biomarker for early diagnosis

@ast

Aberrant methylation of p16(IN ...... biomarker for early diagnosis

@en

type

label

Aberrant methylation of p16(IN ...... biomarker for early diagnosis

@ast

Aberrant methylation of p16(IN ...... biomarker for early diagnosis

@en

prefLabel

Aberrant methylation of p16(IN ...... biomarker for early diagnosis

@ast

Aberrant methylation of p16(IN ...... biomarker for early diagnosis

@en

P1433

Q36324689-853F199B-9978-4938-B51F-95262776F090

P1476

Q36324689-049A510C-B99C-424E-B2F3-D0BBDCF307E8

P2093

Q36324689-0C8BA95F-A617-4172-87EE-2B171AF8A01D

Q36324689-284661D2-451E-493C-A21F-E6D38A5B03BC

Q36324689-44E3606F-B5DE-48DC-8062-F8565B5F841D

Q36324689-86AD9F20-12CC-41D0-AA81-733B76CDBC71

Q36324689-A430859F-27AC-424F-81B7-8EAAE989EF09

Q36324689-CB462D6C-58B3-4ECC-A668-985EB12438C0

Q36324689-D26BDAD0-682C-4186-8FCA-754936E3E94D

Q36324689-FCC5D434-1169-4836-A9E3-FCD3EA82504C

P2860

Q36324689-09DAADDD-1E96-4A15-A24C-E395225E8660

Q36324689-0D07BCD8-AFB6-4DBC-94B3-3879D7549969

Q36324689-158A4432-9F1F-4B00-9E8D-4F14E454CFBA

Q36324689-29E8441D-97BD-4474-A3C0-3DC05F91987F

Q36324689-3554D9EF-ED45-44F2-8EE8-AA988A096E7F

Q36324689-35660226-374B-46BD-A206-A0CC9A2913F4

Q36324689-3F7489DF-00BD-4522-8333-0D6F1E35CB93

Q36324689-3FF22C51-F231-47BD-9CE8-374D8D770A8E

Q36324689-44DA1DA1-2CC7-4955-94EA-D42E39CC9DD8

Q36324689-905F6D24-F284-459B-96F4-67427E3E6438

P304

Q36324689-4134AE26-D79E-47A6-8EF9-F006EE103DC5

P31

Q36324689-F16B4D66-907E-4EA8-B841-DFB644CFAEC2

P356

Q36324689-DF504F88-9C08-4BFE-8067-556191F026FD

P407

Q36324689-02079E81-6DF2-4C88-8510-133DA9F0536D

P433

Q36324689-C7CFB55F-4B3B-4D12-B4BB-8FEE51712803

P478

Q36324689-798116C8-8816-448A-9FA0-9DDAA6D06B32

P577

Q36324689-7FD9ADE8-49FC-41D5-A68B-5B6EDF5CC71D

P5875

Q36324689-DDD0965A-9BA0-4503-9B2B-BE56E9AAFB38

P698

Q36324689-2D44CD59-97C0-4015-A6CD-1D4318FFAE2F

P921

Q36324689-67A337A7-08AF-4478-B29E-16246ED6A914

P932

Q36324689-C7BF9EC6-E3FA-4C50-9235-7A9645FE33E2

P356

PNAS.95.20.11891

P1433

Proceedings of the National Academy of Sciences of the United States of America

P1476

Aberrant methylation of p16(IN ...... biomarker for early diagnosis

@en

P2093

E Gabrielson

http://www.w3.org/2001/XMLSchema#string

G Saccomanno

http://www.w3.org/2001/XMLSchema#string

J G Herman

http://www.w3.org/2001/XMLSchema#string

K J Nikula

http://www.w3.org/2001/XMLSchema#string

R Michels

http://www.w3.org/2001/XMLSchema#string

S A Belinsky

http://www.w3.org/2001/XMLSchema#string

S B Baylin

http://www.w3.org/2001/XMLSchema#string

W A Palmisano

http://www.w3.org/2001/XMLSchema#string

P2860

Detection of trisomy 7 in nonmalignant bronchial epithelium from lung cancer patients and individuals at risk for lung cancer

Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands

A cell cycle regulator potentially involved in genesis of many tumor types

Molecular damage in the bronchial epithelium of current and former smokers.

A prognostic model of recurrence and death in stage I non-small cell lung cancer utilizing presentation, histopathology, and oncoprotein expression.

Frequent aberrant methylation of p16INK4a in primary rat lung tumors.

Reciprocal Rb inactivation and p16INK4 expression in primary lung cancers and cell lines.

CDKN2 gene silencing in lung cancer by DNA hypermethylation and kinetics of p16INK4 protein induction by 5-aza 2'deoxycytidine.

Dose-response relationship between O6-methylguanine formation in Clara cells and induction of pulmonary neoplasia in the rat by 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone.

Lung carcinoma in former smokers.

P304

11891-11896

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1073/PNAS.95.20.11891

http://www.w3.org/2001/XMLSchema#string

P407

P433

20

http://www.w3.org/2001/XMLSchema#string

P478

95

http://www.w3.org/2001/XMLSchema#string

P577

1998-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

235615027

http://www.w3.org/2001/XMLSchema#string

P698

9751761

http://www.w3.org/2001/XMLSchema#string

P921

P932

21736

http://www.w3.org/2001/XMLSchema#string